baber/WOPTO huggingface dataset:
Patent JP-3210113-B2 (JP)
IPC: G05G1/00
Filed: 1992-12-17
Granted: 2001-09-17
Abstract: PURPOSE:To facilitate mounting of a decorative piece by a method wherein an engaging protrusion formed in a manner to protrude from the under surface of the decorative piece is pressed in a throughhole, formed in the central part of the ceiling wall of a core, through a leather and engaged with the back of the ceiling wall. CONSTITUTION:A leather-wound gear shift knob comprises a core 12 having a screw hole 11, formed in a central part and capable of being joined in a screwed-in state with the tip of a gear shift lever, and a hollow pat 10 provided at an upper end with a ceiling wall 24; an intermediate member 13 with which the outer periphery of the core 12 is wrapped; and a leather skin member 3 with which the outer periphery of the intermediate member 13 is surrounded. A through-hole 25 extending to the hollow part 10 is formed in the central part of the ceiling wall 24. The tip large part 29 of an engaging protrusion 20 protruded from the under surface of a decorative piece 5 is pressed in the through-hole 25 through the leather skin member 3 to engage the large part 29 with the back 26 of the ceiling wall 24. When the through-hole 19 of a central leather 16 is caused to coincide with the engaging hole 25 of the core 12 and the protrusion part 20 of the decorative piece 5 is pressed in from above, the tip large part 29 at the lower part of the protrusion part 20 is engaged through the engaging hole 25 with the back 26 of the ceiling wall 24. The decorative piece 5 and the central leather 16 are not only accurately registered with a mounting member 2 but also causes elimination of a surplus process.
Patent JP-H0536589-B2 (JP)
IPC: E04H/
Filed: 1987-12-08
Abstract: PCT No. PCT/SE87/00583 Sec. 371 Date Jul. 26, 1988 Sec. 102(e) Date Jul. 26, 1988 PCT Filed Dec. 8, 1987 PCT Pub. No. WO88/04350 PCT Pub. Date Jun. 16, 1988.A vehicle transporting arrangement, primarly intended for private cars, whereby a vehicle is intended to be transported to a parking space in a vehicle parking building without the assistance of a driver and without the vehicle being rolled on its wheels. According to the invention the transporting arrangement comprises eight lifting blocks (101-108) which are intended to be placed in pairs on both sides of a vehicle wheel. The lifting blocks (101-108) are intended to lift all wheels of the vehicle free from a supporting surface (111). Each lifting block includes a wheel or like device intended for rolling against the supporting surface (111) when the vehicle is in a raised position. The four pairs of lifting blocks (101, 102; 103, 104; 105, 106; 107, 108) are arranged for movement relative to one another, wherein two lifting block pairs (101, 102; 103, 104) are included in a first lifting unit (200) and wherein two lifting block pairs (105, 106; 107, 108) are included in a second lifting unit (201). The two units can be displaced relative to one another, whereby each of the respective lifting block pairs can be moved to a position adjacent a respective wheel of the vehicle such that the two lifting blocks in each respective pair are located on both sides of a respective vehicle wheel when a vehicle has been placed in a pre-determined position relative to the transporting arrangement.
Patent JP-2661930-B2 (JP)
IPC: G06F21/62
Filed: 1987-04-20
Granted: 1997-10-08
Abstract: A portable data carrier (10) typically the size of a standard plastic credit card is usable in a variety of applications, from custom repertory dialing to storage of individual medical and/or banking records. The portable data carrier provides a high security file system capable of supporting multiple applications, all independent of the details of the data carrier's generic internal structure. Although the data carrier looks and feels much like an ordinary credit card, it includes a computer (110) and an electrically erasable programmable read-only memory (115). Power for operation of the portable data carrier is provided from an associated station (118) via a reader/writer (15). The reader/writer also couples data between the data carrier and the associated station. Security is enhanced since application software in the station receiving and interpreting the data from a file sees a contiguous stream of bytes relating only to the file of the application being accessed. No information is provided to a user of a particular application about other applications in the data carrier or about the data carrier's internal file structure.
Patent JP-3417566-B2 (JP)
IPC: C07D471/06
Filed: 1996-06-20
Granted: 2003-06-16
Abstract: The use of human CB2 receptor-specific agonists of formula (I) or (I') for preparing immunomodulating drugs is disclosed. In formulae (I) and (I'), R1 is a group selected from -CH2CHR10NR6R11, -(CH2)2NR'6R'11, -CHR9CH2NR'6R'11, -(CH2)nZ and -COR8; R'1 is a -CH2CHR10NR6R11 or -(CH2)2NR'6R'11 group; R2 and R'2 are hydrogen, halogen or C1-4 alkyl; R3 is hydrogen, C1-4 alkyl or a group selected from -CH2CHR10NR6R11, -(CH2)2NR'6R'11 and -COR8; R'3 is a =CR6R8 group; R4 has one of the meanings given for R5 or is a -COR8 group; R5 is hydrogen, C1-4 alkyl, C1-4 alkoxy, a halogen atom, a CF3 group, an OCF3 group or C1-4 alkylthio; R'5 has one of the meanings given for R5 and is in the 5 or 6 position of the indene ring; R6 is hydrogen or C1-4 alkyl; R'6 is C1-4 alkyl; R7 has one of the meanings given for R5 or R7 and R9 together form a -Y-CH2- group attached to the indole ring in the 7 position by a group Y; R8 is phenyl substituted one to four times by a substituent selected from halogen, C1-4 alkyl or C1-4 alkoxy; a polycyclic ring selected from naphth-1-yl, naphth-2-yl, 1,2,3,4-tetrahydronaphth-1-yl, 1,2,3,4-tetrahydronaphth-5-yl, anthryl, benzofuryl, benzothien-2-yl, benzothien-3-yl, 2-, 3-, 4- or 8-quinolyl, said polycyclic rings optionally being substituted once or twice by a substituent selected from C1-4 alkyl, C1-4 alkoxy, C1-4 alkylthio, halogen, cyano, hydroxyl, trifluoromethyl and imidazol-1-yl; R10 and R11 together are a group selected from -CH2-O-CH2-CR12R13- and -(CH2)p-CR12R13-, wherein the carbon atom substituted by R12 and R13 is attached to the nitrogen atom; R'11 is C1-4 alkyl; or R'11 and R'6, taken together with the nitrogen atom to which they are attached, form a group selected from morpholin-4-yl, thiomorpholin-4-yl, piperidin-1-yl and pyrrolidin-1-yl; each of R12 and R13 is independently hydrogen or C1-4 alkyl; n is 2, 3, 4 or 5; p is 2 or 3; Z is a methyl group or a halogen atom; and Y is a methylene group or an oxygen atom.
Patent JP-H0737464-B2 (JP)
IPC: C07K16/00
Filed: 1987-04-30
Abstract: Novel compounds for use in electrochemiluminescent assays and characterised by containing the structure        X - Y - ZwhereinX represents one or more nucleotides which may be the same or different, one or more amino acids which may be the same or different, an antibody, an analyte of interest or an analogue of an analyte of interestY represents a linker group attached to X and Z,andZ represents an electrochemiluminescent moiety, and intermediates employed in their synthesis.
Patent JP-3703498-B2 (JP)
IPC: A01J5/04
Filed: 1997-07-01
Granted: 2005-10-05
Abstract: The milking machine consists of a milk box (1) with a robot arm (3). The robot arm can move longitudinally on rails (5&6). Control cylinder (20) permits the robot arm to move sideways around pivot point (16). The milking robot that has automatically connecting teat cups (25) and a detector (26) which can determine the position of the animal's teats.
Patent JP-3182729-B2 (JP)
IPC: B65D71/12
Filed: 1993-07-26
Granted: 2001-07-03
Abstract: A bottle carrier for packaging and gripping in a taut fashion a plurality of bottles includes top (1), bottom (47) and side walls, each side wall having a substantially vertically disposed bottom portion (21, 35) and an inwardly inclined top portion (6, 8) foldably joined to the bottom portion to form a tubular structure, top end panels (2, 4) foldably joined to each end edge of the top wall together with a bottom end panel (49, 51) foldably joined to each of the bottom wall and secured in overlapping relation with the associated top end panel. A first collapsible web is (15, 17) foldably joined to each end edge of each top end panel (2, 4) and to the end edge of each of the inwardly inclined top wall portion (6, 8). A yieldable fold line (30, 31) formed in each collapsible web (15, 17) extends from the adjacent corner of the top wall downwardly in angular relation to the adjacent end edge of the associated inwardly inclined top wall portion (6, 8).
Patent JP-3395138-B2 (JP)
IPC: D21B1/02
Filed: 1994-07-19
Granted: 2003-04-07
Abstract: An improved method of processing baled waste material containing waste paper having fibers contaminated to various degrees for recovering usable cellulosic fiber pulp from the bale in which the bale contents are impregnated with a fiber swelling and debonding fluid by enclosing the bale within a closed chamber and subjecting the chamber and contained bale to multiple pressure environmental conditions, that preferably includes a vacuum, while submerging the bale in the debonding fluid. The impregnated bale contents are allowed to soak for a sufficient period that the lesser degree contaminated fibers become swollen after which the bale is subjected to a sufficiently low degree of pulping agitation as initiates separation of the swollen fibers without significant damage to the fibers and which does not significantly decrease the sheet size of higher degree contaminated bonded fibers and other contaminants. The agitated bale contents are separated in a screen separator into a pulp containing slurry and a reject mass of higher degree contaminated, unswollen fibers and contaminants. If the reject mass contains a significant degree of fibrous material, it is compressed into bale form and again subjected to a multiple pressure liquid impregnation treatment in a closed chamber after which the multiple pressure impregnated bale is subjected to the same or similar recycling operations in separating out the fiber pulp slurry.
Patent JP-3616644-B2 (JP)
IPC: G01N33/493
Filed: 1995-07-28
Granted: 2005-02-02
Abstract: Method and device for measuring the concentration or urea or a similar substance, in a composite solution, particularly a dialysis solution, by catalytic decomposition of urea by urease. The differential conductivity of the reacted and unreacted solution is measured and is proportional to the urea concentration. A sample solution is taken out from the composite solution by a pump (6) and divided into two branches. The first branch passes a reactor column (10), a temperature equalizing coil (71) and a first measurement cell (7a), and the second branch passes a delay vessel (22), a temperature equalizing coil (72) and a second measurement cell (7b). <IMAGE>
Patent JP-3062953-B2 (JP)
IPC: C09D101/28
Filed: 1990-05-10
Granted: 2000-07-12
Abstract: A sprayable composition and a method of protecting material with the composition is disclosed. The composition comprises a polymer such as hydroxyethyl cellulose, clay, and water to provide a cover layer which, after spraying, is tough, flexible and water-repellent. Other materials such as shredded paper and gypsum can be used in the cover layer. The composition is effective as a cover layer over material such as soil, refuse at a dump site, or grain in a stockpile.
Patent JP-3350048-B2 (JP)
IPC: A61K31/56
Filed: 1990-07-05
Granted: 2002-11-25
Abstract: A method of treatment of androgen-related diseases such as prostate cancer in susceptible male animals, including humans, comprises administering novel antiandrogens and/or novel sex steroid biosynthesis inhibitors as part of a combination therapy. Sex steroid biosynthesis inhibitors, especially those capable of inhibiting conversion of dehydroepiandrosterone (DHEA) or 4-androstenedione ( DELTA 4-dione) to natural sex steroida (and testosterone into dihydrotestosterone) in peripheral tissues, are used in combination with antiandrogens usually after blockade of testicular hormonal secretions. Antiestrogens can also be part of the combination therapy. Pharmaceutical compositions and two, three, four and five component kits are useful for such combination treatment.
Patent JP-4162267-B2 (JP)
IPC: A61K39/095
Filed: 1997-08-04
Granted: 2008-10-08
Abstract: The present invention pertains generally to novel Neisseria meningitidis serogroup B glycoconjugates. More particularly, the invention pertains to glycoconjugates formed from a Neisseria meningitidis serogroup B capsular oligosaccharide derivative (MenB OS derivative) in which sialic acid residue N-acetyl groups are replaced with N-acyl groups. The invention also pertains to vaccine formulations containing the glycoconjugates, methods of making the vaccine formulations, and methods of using the vaccine formulations to treat or prevent Neisseria meningitidis serogroup B or E. coli K1 disease in a mammalian subject.
Patent JP-H081829-B2 (JP)
IPC: H05B6/10
Filed: 1990-08-27
Abstract: PCT No. PCT/DE90/00654 Sec. 371 Date Feb. 19, 1992 Sec. 102(e) Date Feb. 19, 1992 PCT Filed Aug. 27, 1990 PCT Pub. No. WO91/03916 PCT Pub. Date Mar. 21, 1991.A device for inductively heating flat metal objects, with at least one pair of induction coils which form a gap through which the object is moved. The induction coils have an iron core made up of transformer stampings with grooves in which current conductors are arranged. The iron cores of at least one inductor coil have grooves which run in a zig-zag or undulating fashion along the direction of motion of the object being heated. The maximum angle the grooves make with the direction of movement of the object is 60 DEG , and the current conductors are disposed in the grooves so as to follow the zig-zags or undulations thereof. The inductor coils of at least one inductor-coil pair include several side-by-side conductors which are arranged so as to carry current in the same direction along the coil. At least some of the current conductors are arranged for selective independent electrical connection to a source of electrical energy.
Patent JP-3194433-B2 (JP)
IPC: G21G4/08
Filed: 1990-07-11
Granted: 2001-07-30
Abstract: PCT No. PCT/US90/03897 Sec. 371 Date Jan. 23, 1992 Sec. 102(e) Date Jan. 23, 1992 PCT Filed Jul. 11, 1990.The invention relates to a method of preparing a radiodiagnostic comprising a gaseous radionuclide formed by radioactive decay of a parent nuclide, by eluting with a suitable eluent the radioactive daughter nuclide from the parent nuclide provided ionically on a carrier, by using as a carrier for the parent nuclide ions a membrane, in particular an ion exchange membrane, past which the eluent is made to flow. The invention further relates to a radionuclide generator suitable for using said method.
Patent JP-4187268-B2 (JP)
IPC: F03D5/00
Filed: 1997-09-19
Granted: 2008-11-26
Abstract: Method and apparatus for converting the kinetic energy of a moving fluid stream into useful work by using a cascade of thin aero or hydro foils positioned therein. The foils may be provided with at least two degrees of freedom and adjacent foils move out of phase. The foils are subjected to fluid induced oscillations known as flutter. Barriers (3, 43) may be positioned upstream, above, or at sides of the apparatus for increasing efficiency by increasing the fluid velocity. A system of flywheels (17, 18) are used to increase inertia of the foils and are particularly useful with hydrofoils. A cascade of aero or hydro foils may be mechanically oscillated to transfer energy to a fluid.
Patent JP-3535519-B2 (JP)
IPC: C12Q1/68
Filed: 1994-11-29
Granted: 2004-06-07
Abstract: This invention presents novel purine-based compounds for inclusion into oligonucleotides. The compounds of the invention, when incorporated into oligonucleotides are especially useful as "antisense" agents-agents that are capable of specific hybridization with a nucleotide sequence of an RNA. Oligonucleotides are used for a variety of therapeutic and diagnostic purposes, such as treating diseases, regulating gene expression in experimental systems, assaying for RNA and for RNA products through the employment of antisense interactions with such RNA, diagnosing diseases, modulating the production of proteins, and cleaving RNA in site specific fashions. The compounds of the invention include novel heterocyclic bases, nucleosides, and nucleotides. When incorporated into oligonucleotides, the compounds of the invention can be useful for modulating the activity of RNA.
Patent JP-3054443-B2 (JP)
IPC: A23L13/40
Filed: 1993-03-30
Granted: 2000-06-19
Abstract: Heat-stable and fracturable spray-dried free-flowing flavor oil capsules are made by coacervation and used in a wide variety of flavoring foods such as deep fat frying, baking, microwaving, and extrusion applications.
Patent JP-3611575-B2 (JP)
IPC: G01N33/84
Filed: 1994-12-22
Granted: 2005-01-19
Abstract: The present invention relates to the field of immunoassays for metal ions. The invention presents: metal ion-ligand coordination complexes ("MLC"), novel ligands, antibodies specific for MLC, immunoassays utiliizing the foregoing, and methods for selecting said antibodies.
Patent JP-3260762-B2 (JP)
IPC: B29C53/56
Filed: 1995-12-20
Granted: 2002-02-25
Abstract: The present invention relates to a manufacturing method of applying dry powder in a controlled manner to a variety of surfaces to form shapes, coatings, or composite materials. This is achieved by coating the surface with a tacky substance, applying the powder, and then coating the powder with a barrier coating that is insoluble in the solvent used in the tacky layer. The process is repeated to add the desired amount of powder. By the selection of powder size, size distribution, shape, and number of layers, precise control of mass loading can be achieved. The method can be used with titanium powder to form powder-coated fiber, non-woven mat, and tape cast performs which can be processed into fiber reinforced composite materials.
Patent JP-3632856-B2 (JP)
IPC: C07C43/196
Filed: 1994-03-15
Granted: 2005-03-23
Abstract: Chemiluminescent bioassays for the presence or concentration of an analyte in a sample use 1,2-dioxetanes as substrates for the enzyme of an enzyme complex that bind to the analyte. The chemiluminescence obtained from the decomposition of the dioxetane triggered by the enzyme through the formation of the corresponding 1,2-dioxetane oxyanion of the enzyme complex is enhanced by the addition of TBQ as an enhancement agent. Other polymeric quaternary onium salts can be used as enhancement agents in conjunction with enhancement additives which improve the ability of the enhancement agent to form hydrophobic regions in the aqueous sample, in which regions the 1,2-dioxetane oxyanion and its chemiluminescent decomposition products can be sequestered. A kit for performing such assays is also provided.
Patent JP-3597862-B2 (JP)
IPC: A61K38/04
Filed: 1994-03-09
Granted: 2004-12-08
Abstract: PCT No. PCT/EP94/00713 Sec. 371 Date Jan. 17, 1996 Sec. 102(e) Date Jan. 17, 1996 PCT Filed Mar. 9, 1994 PCT Pub. No. WO94/22907 PCT Pub. Date Oct. 13, 1994Urea derivates are disclosed having the formula (I).    <IMAGE>  (I)  in which A, B, W, Z, R, R1, R2, R3 and r have the meaning given in the description, as well as a process for preparing the same and their use as inhibitors of thrombocyte aggregation, carcinom cell metastasis and osteoclast binding to bone surface.
Patent JP-3724807-B2 (JP)
IPC: C09K11/62
Filed: 1995-07-20
Granted: 2005-12-07
Abstract: A luminescent glass includes nanocrystalline semiconductor particles, such as ZnS nanocrystals, and an activator, such as copper, for the particles. The glass is made by depositing the nanocrystalline semiconductor particles and the activator within a porous glass matrix, such as 7930 Vycor TM  and then thermally activating the glass. The porous glass matrix may be at least partially consolidated or may be allowed to remain porous. The nanometer particle size permits the luminescent glasses of the present invention to be transparent to its luminescent emissions.
Patent JP-4014220-B2 (JP)
IPC: C07D233/54
Filed: 1996-01-18
Granted: 2007-11-28
Abstract: Bis-sulfonamido hydroxyethylamino compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease. The present invention relates to retroviral protease inhibiting compounds of the formula: <CHEM> or a pharmaceutically acceptable salt, prodrug or ester thereof, wherein the variables are as defined herein.
Patent JP-2911607-B2 (JP)
IPC: D03D15/283
Filed: 1995-04-12
Granted: 1999-06-23
Abstract: A process for preparing inherently light- and heat-stabilized polyamides comprises polymerizing in the presence of at least one triacetonediamine compound of the formulawhere R is hydrogen or hydrocarbyl having from 1 to 20 carbon atoms, preferably alkyl having from 1 to 18 carbon atoms, or benzyl.
Patent JP-4176829-B2 (JP)
IPC: B60K17/10
Filed: 1996-04-25
Granted: 2008-11-05
Abstract: A hydraulic drive system for a vehicle includes a pressurizing circuit and a working circuit that are interconnected by suitable valving. The pressurizing circuit incorporates a fixed displacement pump which is driven by a prime mover having a nominal horsepower rating. The prime mover is shifted between an idling speed when the pressure sensed within the pressurizing circuit is within a desired range and an optimum high RPM range when the pressure within the pressurizing circuit falls below the desired range. At least one accumulator is provided in the pressurizing circuit. The working circuit includes a plurality of motor units for driving the vehicle wheels and a plurality of motor control valves which can be placed in a de-activated position to isolate the associated motor unit from the flow of pressurized fluid and an activated position wherein the motor unit aids in driving the vehicle. The vehicle is shifted between various gear ranges by controlling the activation/de-activation of the motor control valves such that, as vehicle speed and drive resistance decreases, the number of motor units being used to propel the vehicle is reduced from a maximum number of four motor units to a single motor unit. A flow control valve is provided to alter the volume of fluid flowing to the various motor units based on desired speed/acceleration parameters as determined by the vehicle operator through a conventional accelerator pedal.
Patent JP-3807681-B2 (JP)
IPC: A61F2/30
Filed: 1997-04-21
Granted: 2006-08-09
Abstract: PCT No. PCT/DE97/00793 Sec. 371 Date Oct. 21, 1998 Sec. 102(e) Date Oct. 21, 1998 PCT Filed Apr. 21, 1997 PCT Pub. No. WO97/39702 PCT Pub. Date Oct. 30, 1997The invention concerns a screw-in type artificial hip joint socket with a special thread for implantation in human beings. Hip joint sockets of this type usually have a flat thread with parallel teeth flanks or a triangular thread with a neutral teeth position, the axial pitch being conventionally constant. However, such embodiments are unfavourable because they do not take sufficiently into account the forces which arise during implantation as well as during the intended use, or they cause an unnecessarily extensive bone bed destruction during an eventually required explantation. With the invention a purposefully optimization of the hip joint socket thread is provided, wherein the thread profile, the angular orientation of the thread teeth and a non-linear thread pitch is utilized, in order to ensure an effortless screwing, a stable seat in the long term and an unproblematic explantation (FIG. 3).